Novo Nordisk Announces Analysis of Wegovy Pill Use in Clinical Practice
Novo Nordisk announced an analysis of Wegovy pill use in clinical practice.
Related stories
Trading halted in HG
CIRO said trading in HG was halted.
L impact | EQUITY | Oct 29, 2026, 07:42 PM UTC
APi Group Reports Third-Quarter Revenue of $2.55 Billion
APi Group said third-quarter 2026 revenue rose 22.5% year over year to $2.55 billion, net income increased 21.4% to $102 million, and diluted EPS gained 20% to $0.24. The company c
M impact | EQUITY | Oct 29, 2026, 07:41 PM UTC
Stagwell Reports Third-Quarter 2026 Revenue of $816.03 Million
Revenue rose 9.8% year over year to $816.03 million. Net revenue grew 8.1%, including 7.4% organic growth; net income and diluted EPS declined.
M impact | EQUITY | Oct 29, 2026, 07:41 PM UTC
Insperity Reports Third-Quarter Revenue of $1.65B, Net Loss of $1M
Third-quarter 2026 revenue rose 1.7% year over year. Net loss narrowed to $1M from $20M, and diluted loss per share improved to $0.02 from $0.53. Higher revenue per worksite employ
M impact | EQUITY | Oct 29, 2026, 07:41 PM UTC
AST SpaceMobile Shares Gain Up to 6% After FCC Advances Satellite Spectrum Proposal
AST SpaceMobile shares rose as much as 6% on Thursday after the FCC advanced a proposal to expand spectrum available for satellites to connect directly to ordinary phones.
M impact | EQUITY | Oct 29, 2026, 07:39 PM UTC
Amgen Announces Dividend of R$ 0.325209295 per Unit
Amgen announced a fourth-quarter 2026 dividend of R$ 0.325209295 per unit.
M impact | EQUITY | Oct 29, 2026, 07:35 PM UTC